SBRA icon

Sabra Healthcare REIT

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 50%
Negative

Negative
Seeking Alpha
12 days ago
The State Of REITs: November 2025 Edition
The REIT sector has seen back-to-back tough months as it saw a modest average negative total return in September (-0.73%) and fell deeper into the red in October (-4.03%). Small cap REITs (-5.05%) had the worst performance in October. Micro caps (-2.81%), mid caps (-3.11%) and large caps (-4.45%) were also in negative territory albeit to a smaller degree. Only 21.66% of REIT securities had a positive total return in October.
The State Of REITs: November 2025 Edition
Neutral
Seeking Alpha
24 days ago
Sabra Health Care REIT, Inc. (SBRA) Q3 2025 Earnings Call Transcript
Sabra Health Care REIT, Inc. ( SBRA ) Q3 2025 Earnings Call November 6, 2025 1:00 PM EST Company Participants Lukas Hartwich - Executive Vice President of Finance Rick Matros - Chairman, President & CEO Talya Nevo-Hacohen - Executive VP, Chief Investment Officer & Treasurer Darrin Smith - Executive Vice President of Investments Michael Costa - Executive VP, CFO & Secretary Conference Call Participants Farrell Granath - BofA Securities, Research Division Austin Wurschmidt - KeyBanc Capital Markets Inc., Research Division William John Kilichowski - Wells Fargo Securities, LLC, Research Division Seth Bergey - Citigroup Inc., Research Division Juan Sanabria - BMO Capital Markets Equity Research Richard Anderson - Cantor Fitzgerald & Co., Research Division Alec Feygin - Robert W. Baird & Co. Incorporated, Research Division Michael Stroyeck - Green Street Advisors, LLC, Research Division Omotayo Okusanya - Deutsche Bank AG, Research Division Presentation Operator Good day, everyone.
Sabra Health Care REIT, Inc. (SBRA) Q3 2025 Earnings Call Transcript
Positive
Zacks Investment Research
25 days ago
Sabra (SBRA) Reports Q3 Earnings: What Key Metrics Have to Say
The headline numbers for Sabra (SBRA) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Sabra (SBRA) Reports Q3 Earnings: What Key Metrics Have to Say
Positive
Zacks Investment Research
25 days ago
Sabra Healthcare (SBRA) Meets Q3 FFO Estimates
Sabra Healthcare (SBRA) came out with quarterly funds from operations (FFO) of $0.38 per share, in line with the Zacks Consensus Estimate . This compares to FFO of $0.37 per share a year ago.
Sabra Healthcare (SBRA) Meets Q3 FFO Estimates
Neutral
Business Wire
25 days ago
Sabra Reports Third Quarter 2025 Results; Updates 2025 Guidance
TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #3Q25--Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced its results of operations for the third quarter of 2025. THIRD QUARTER 2025 RESULTS AND RECENT EVENTS Results per diluted common share for the third quarter of 2025 were as follows: Net Income: $0.09 FFO: $0.33 Normalized FFO: $0.36 AFFO: $0.37 Normalized AFFO: $0.38 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 2.35x Senior Housing - Leased: 1.52x Behavi.
Sabra Reports Third Quarter 2025 Results; Updates 2025 Guidance
Positive
Zacks Investment Research
26 days ago
Sabra (SBRA) Upgraded to Buy: Here's Why
Sabra (SBRA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Sabra (SBRA) Upgraded to Buy: Here's Why
Neutral
Business Wire
1 month ago
Sabra Health Care REIT, Inc. Announces Third Quarter 2025 Earnings Release Date and Conference Call
TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #3Q25--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that it will issue its 2025 third quarter earnings release on November 5, 2025, after the close of trading. A conference call with a simultaneous webcast to discuss the 2025 third quarter results will be held on Thursday, November 6th at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference.
Sabra Health Care REIT, Inc. Announces Third Quarter 2025 Earnings Release Date and Conference Call
Positive
Seeking Alpha
1 month ago
Sabra Health Care: SHOP Model As A Value Catalyst
Sabra Health Care REIT is rated a buy with a target price of $19.22, driven by FFO growth and SHOP portfolio expansion. SBRA's shift toward a larger Senior Housing Operating Portfolio aims to capture higher NOI growth, though it introduces more volatility than NNN leases. The REIT offers a 6.6% dividend yield, with improving payout ratios and strong dividend sustainability supported by projected FFO growth.
Sabra Health Care: SHOP Model As A Value Catalyst
Neutral
Business Wire
1 month ago
Sabra Health Care REIT, Inc. to Attend the AHCA/NCAL Convention & Expo
TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #AHCA--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Talya Nevo-Hacohen, the company's Chief Investment Officer, Kara Pappanduros, the company's Senior Vice President of Asset Management, and other members of the company, will attend the AHCA/NCAL Convention & Expo, Delivering Solutions 25 on October 19-22, 2025, at the South Convention Center of the Mandalay Bay Resort & Casino in Las Vegas, Nevada. Ms. Nevo-Hacohen will participate in an In.
Sabra Health Care REIT, Inc. to Attend the AHCA/NCAL Convention & Expo
Positive
Seeking Alpha
2 months ago
Sabra Health Care: Buy This High Yield While It's Undervalued
Sabra Health Care REIT is an undervalued healthcare REIT benefiting from demographic tailwinds and strong fundamentals. SBRA's diversified portfolio, rising occupancy, robust rent coverage, and standout SHOP segment drive solid FFO growth and stability. Disciplined capital allocation, improved balance sheet, and strategic operator transitions support a well-covered 6.4% dividend yield.
Sabra Health Care: Buy This High Yield While It's Undervalued